Provided by Tiger Trade Technology Pte. Ltd.

Ventyx Biosciences, Inc.

14.00
0.0000
Volume:- -
Turnover:76.26M
Market Cap:1.00B
PE:-9.34
High:14.00
Open:14.00
Low:14.00
Close:14.00
52wk High:25.00
52wk Low:0.7830
Shares:71.75M
Float Shares:53.56M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4991
EPS(LYR):-1.9732
ROE:-45.35%
ROA:-28.47%
PB:5.25
PE(LYR):-7.10

Loading ...

Premarket Movers | Ventyx Biosciences Rockets 68%; Critical Metals Surges 11%; Mobileye Jumps over 10%; Strategy Gains 6%

Tiger Newspress
·
Jan 07

PRESS DIGEST -Wall Street Journal - January 7

Reuters
·
Jan 07

Sandisk, Alumis, Micron Technology, Ventyx Biosciences, And Western Digital: Why These 5 Stocks Are On Investors' Radars Today

Benzinga_recent_news
·
Jan 07

24H | Ventyx Soars 63%; Mobileye Surges 10%; Terrestrial Energy Jumps Another 9%; Strategy Gains 6%

Tiger Newspress
·
Jan 07

Ventyx Biosciences Stock Soars 62% After Lilly in Talks to Buy Company for More Than $1 Billion

Reuters
·
Jan 07

Eli Lilly Reportedly in Talks to Acquire Ventyx Biosciences, Sending Target's Shares Soaring Over 50% After Hours

Deep News
·
Jan 07

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

Dow Jones
·
Jan 07

BRIEF-Eli Lilly In Advanced Talks To Buy Ventyx Biosciences For Over $1 Billion - WSJ

Reuters
·
Jan 07

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences for Over $1 Bln - WSJ

THOMSON REUTERS
·
Jan 07

BRIEF-Ventyx Provides Clinical And Corporate Updates

Reuters
·
Dec 02, 2025

Ventyx Biosciences Expands Phase 2 Recurrent Pericarditis Study Into Canada, EU, UK

MT Newswires Live
·
Dec 02, 2025

Ventyx Biosciences Inc: Revising Guidance for Topline Data Release From Interim Analysis of Phase 2 Rp Trial to Q1 2026

THOMSON REUTERS
·
Dec 02, 2025

Ventyx Provides Clinical and Corporate Updates

GlobeNewswire
·
Dec 02, 2025

Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline

Benzinga
·
Dec 02, 2025

Ventyx Biosciences to Join Piper Sandler Annual Healthcare Conference

Reuters
·
Dec 01, 2025

Ventyx Biosciences Q3 EPS USD -0.32

Reuters
·
Nov 20, 2025

Ventyx Biosciences to Join Jefferies Global Healthcare Conference in London

Reuters
·
Nov 17, 2025

Ventyx Biosciences Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 08, 2025

Promising Pipeline and Data Updates Justify Buy Rating for Ventyx Biosciences

TIPRANKS
·
Nov 07, 2025

Stock Track | Ventyx Biosciences (VTYX) Plummets 5.47% Pre-Market Despite Analyst Upgrades, Q3 Earnings May Disappoint

Stock Track
·
Nov 07, 2025